1991
DOI: 10.1016/0041-008x(91)90298-s
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for arsenic as the immunosuppressive component of gallium arsenide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
29
0
1

Year Published

1994
1994
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(30 citation statements)
references
References 25 publications
0
29
0
1
Order By: Relevance
“…GaAs may cause a local inflammatory reaction in the peritoneum, leading to the augmented functional capability of the macrophages, similar to the pulmonary inflammation induced after intratracheal instillation of the chemical [32,33]. On the other hand, GaAs dissociates in vivo, and gallium and arsenic components are present in the blood and various organs up to 14 days after a single exposure by intratracheal, oral, or intraperitoneal administration [34][35][36]. Gallium is a competitive inhibitor of zinc-and iron-dependent enzymes [33,37].…”
Section: Discussionmentioning
confidence: 99%
“…GaAs may cause a local inflammatory reaction in the peritoneum, leading to the augmented functional capability of the macrophages, similar to the pulmonary inflammation induced after intratracheal instillation of the chemical [32,33]. On the other hand, GaAs dissociates in vivo, and gallium and arsenic components are present in the blood and various organs up to 14 days after a single exposure by intratracheal, oral, or intraperitoneal administration [34][35][36]. Gallium is a competitive inhibitor of zinc-and iron-dependent enzymes [33,37].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the immunization of GaAs-treated mice with sheep red blood cells produced a 50% decrease in CD4 + splenic cells after 24 h (Burns and Munson, 1993). The arsenic component of GaAs was shown to be the major contributor to the observed induced immunosuppression (Burns et al, 1991). Sengupta and Bishayi (2002) revealed that arsenic significantly decreased murine splenocyte phagocytic activity.…”
Section: Introductionmentioning
confidence: 99%
“…An alarming number of toxicity cases have been reported in these areas (1), in which arsenic has been found to cause immunotoxicity, immunosuppression, skin lesions, and increased risk of cancer (2)(3)(4)(5)(6). At the same time, renewed attention has been created due to the therapeutic application of arsenic in the treatment of lymphoid and hemopoietic neoplasmas such as acute promyelocytic leukemia (7).…”
mentioning
confidence: 99%
“…Caspase activation may (13,14) or may not (15) be associated with arsenic-induced apoptosis of neoplastic cells. Arsenite has also been shown to induce activation of mitogen-activated protein kinase (MAPK) 3 (2) family member proteins, some of which may play a key role in apoptosis induction in leukemia cells (10). These observations in studies using neoplastic cells, which have partially elucidated the mechanism of arsenite-induced apoptosis, have not, however, enabled clarification of the total signal cascade from the cell surface to the nucleus for arsenite-induced apoptosis of normal lymphocytes, which may be important for a better understanding of the arsenite-induced immunotoxicity and immunosuppression.…”
mentioning
confidence: 99%